샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782950

세계의 뉴로테크 디바이스 시장

Neurotech Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 296 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뉴로테크 디바이스 세계 시장은 2030년까지 303억 달러에 달할 전망

2024년에 152억 달러로 추정되는 뉴로테크 디바이스 세계 시장은 분석 기간인 2024-2030년에 CAGR 12.2%로 성장하여 2030년에는 303억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 신경 자극은 CAGR 10.4%를 기록하며 분석 기간 종료시에는 124억 달러에 달할 것으로 예측됩니다. 신경 인공기관(Neuroprostheses) 분야의 성장률은 분석 기간 CAGR로 14.9%로 추정됩니다.

미국 시장은 추정 41억 달러, 중국은 CAGR 16.1%로 성장 예측

미국의 뉴로테크 디바이스 시장은 2024년에 41억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 63억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 16.1%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 9.1%와 10.7%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.6%로 성장할 것으로 예측됩니다.

세계 뉴로테크 디바이스 시장 - 주요 동향 및 촉진요인 정리

뉴로테크 디바이스는 뇌-컴퓨터 상호작용과 신경 건강에 어떤 혁명을 불러일으키고 있을까?

뉴로테크 디바이스는 뇌-컴퓨터 인터페이스(BCI), 신경자극치료, 인지기능 강화, 실시간 신경 모니터링 등을 통해 인간과 기술의 관계를 변화시키고 있습니다. 이 장치들은 신경과학과 디지털 기술을 연결하여 간질, 우울증, 파킨슨병, 척수손상 등의 증상에 획기적인 솔루션을 제공하고 있습니다. 뇌 임플란트, 웨어러블 신경 자극기, 비침습적 뇌파 기반 시스템은 개인의 운동 능력 회복, 의족 제어, 신경 신호를 이용한 의사소통을 가능하게 하고 있습니다. 뉴로테크는 정신건강 치료에서도 중요한 역할을 하고 있으며, 경두개자기자극(TMS)과 미주신경자극(VNS)은 치료 저항성 우울증과 불안장애에 대한 효과적인 치료법으로 떠오르고 있습니다. 인지 훈련, 집중력 향상, 스트레스 관리를 위한 뉴로피드백 기기의 채택이 확대되고 있어 뉴로테크의 전망은 더욱 넓어지고 있습니다. 인공지능(AI)과 머신러닝의 발전으로 실시간 신경 데이터 분석이 가능해지면서 정밀 신경치료의 길이 열리고 있습니다. 세계 인구의 고령화와 신경 퇴행성 질환의 유행에 따라 뉴로 테크 장치는 주류 의료에 점점 더 많이 통합되어 신경 재활을 강화하고 뇌와 기계의 직접적인 상호 작용을 통해 인간의 잠재력을 확장하고 있습니다.

뉴로테크 디바이스의 보급을 가로막고 있는 과제는 무엇인가?

급속한 발전에도 불구하고, 뉴로테크 장치는 보급을 방해하는 몇 가지 도전에 직면해 있습니다. 주요 장애물 중 하나는 특히 이식형 BCI와 고급 신경조절 치료의 개발 및 도입 비용이 높다는 점입니다. 뇌-컴퓨터 인터페이스와 신경 자극 기술을 둘러싼 윤리적, 규제적 우려는 장기적인 안전성, 프라이버시, 신경 데이터 악용 가능성 등 여전히 시급한 문제이기 때문에 추가적인 장애물이 될 수 있습니다. 뇌 신호 해석의 복잡성과 환자 반응의 편차도 신경기술 적용의 신뢰성과 유효성에 도전이 되고 있습니다. 많은 뉴로테크 디바이스는 큰 연산 능력과 실시간 처리 능력을 필요로 하며, 이는 에너지 소비와 디바이스의 소형화에 대한 우려로 이어지고 있습니다. 또한, 침습적인 뇌 임플란트에 대한 회의적인 시각과 커넥티드 뉴로테크 솔루션의 데이터 보안에 대한 우려로 인해 도입이 더디게 진행되고 있습니다. 다양한 뉴로테크 플랫폼 간의 표준화 및 기존 헬스케어 시스템과의 상호운용성에는 아직 해결되지 않은 문제가 남아있어 임상 워크플로우에 통합하는 데 어려움을 겪고 있습니다. 이러한 문제를 해결하기 위해서는 신경윤리학에 대한 투자를 늘리고, 신경과학자와 엔지니어의 다학제적 협력 체제를 구축하며, 사용자의 접근성과 안전성을 향상시키는 저전력 무선 뉴로테크 솔루션 개발을 추진해야 합니다.

뉴로테크의 한계를 뛰어넘는 혁신이란?

뉴로테크 시장은 급속한 기술 혁신이 이루어지고 있으며, 새로운 기술로 인해 뇌-기계 인터페이스와 신경조절 장치의 기능, 정확성, 접근성이 향상되고 있습니다. 고밀도의 유연한 신경 임플란트의 개발로 뇌 신호의 획득이 향상되고, 장치의 성능이 오래 지속될 수 있게 되었습니다. AI가 탑재된 BCI는 신경 활동을 보다 빠르고 정확하게 해독할 수 있게 해주고, 생각을 직접 제어할 수 있는 장치의 문을 열어주고 있습니다. 기능성 근적외선 분광법(fNIRS), 건식 전극 EEG 헤드셋 등 비침습적 신경기술 솔루션의 등장으로 신경기술은 게임, 생산성 향상, 명상 등 다양한 소비자용 애플리케이션에 더욱 쉽게 활용될 수 있게 되었습니다. 신경 자극도 진화하고 있으며, 실시간 뇌 활동을 기반으로 자극 파라미터를 자동으로 조정하는 폐쇄 루프 피드백 시스템을 통해 간질, 만성 통증 등의 증상에 대한 효과가 향상되고 있습니다. 무선 신경기술의 발전으로 뇌 센서와 외부 기기의 원활한 연결이 가능해지면서 침습적 시술의 필요성이 줄어들고 있습니다. 또한, 뉴로테크와 증강현실(AR), 가상현실(VR)의 융합으로 인지치료, 통증관리, 신경재활에 새로운 가능성이 열리고 있습니다. 기술 혁신이 가속화됨에 따라 뉴로테크는 더욱 정교해지고, 개인화되고, 일상 생활에 통합되어 인간과 컴퓨터의 상호 작용의 미래를 변화시키고 있습니다.

뉴로테크 디바이스 시장의 성장 원동력은?

뉴로테크 디바이스 시장의 성장은 신경질환 유병률 증가, 뇌-기계 인터페이스 연구에 대한 투자 증가, 인지기능 향상 기술에 대한 소비자의 관심 증가 등 여러 요인에 의해 이루어지고 있습니다. 간질, 우울증, 파킨슨병 등의 질환에 대한 비침습적 이식형 디바이스가 FDA의 승인을 받으면서 신경자극치료에 대한 수요가 급증하고 있습니다. AI 기반 뇌-컴퓨터 인터페이스의 확장은 시장 성장을 더욱 촉진하고 있으며, 각 기업은 마인드 컨트롤 의족, 보조 커뮤니케이션 도구, 핸즈프리 컴퓨팅 솔루션 등을 개발하고 있습니다. 수면 개선 및 스트레스 완화를 위한 뉴로피드백 기기 등 웰니스 및 정신건강 분야에서 웨어러블 뉴로테크의 채택이 확대되고 있으며, 임상적 용도 외에도 시장이 확대되고 있습니다. 맞춤형 의료와 실시간 뇌 모니터링의 추진은 차세대 뇌파 및 신경 영상 기술에 대한 투자를 촉진하여 신경학적 진단의 정확성을 높이고 있습니다. 또한, 미국 브레인 이니셔티브(BRAIN Initiative), 유럽 휴먼 브레인 프로젝트(European Human Brain Project) 등 신경기술 연구를 지원하는 정부 이니셔티브가 기술 혁신과 상용화를 촉진하고 있습니다. 뉴로테크 디바이스가 계속 발전함에 따라 그 용도는 헬스케어, 소비자 기술, 국방, 인간 확장으로 확대될 것이며, 향후 몇 년 동안 시장이 급성장할 것으로 보입니다.

부문

제품 유형(신경 자극, 신경 인공기관, 뉴로 센싱, 신경 재활), 병태 유형(파킨슨병, 통증 관리, 인지장애, 간질, 요실금·변실금, 청각장애, 우울증, 수면장애)

조사 대상 기업 사례

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.08

Global Neurotech Devices Market to Reach US$30.3 Billion by 2030

The global market for Neurotech Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$30.3 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Neurostimulation, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Neuroprostheses segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 16.1% CAGR

The Neurotech Devices market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Neurotech Devices Market - Key Trends & Drivers Summarized

How Are Neurotech Devices Revolutionizing Brain-Computer Interaction and Neural Health?

Neurotech devices are transforming the way humans interact with technology, enabling brain-computer interfaces (BCIs), neurostimulation therapies, cognitive enhancement, and real-time neurological monitoring. These devices bridge the gap between neuroscience and digital technology, offering groundbreaking solutions for conditions such as epilepsy, depression, Parkinson’s disease, and spinal cord injuries. Brain implants, wearable neurostimulation devices, and non-invasive EEG-based systems are enabling individuals to regain mobility, control prosthetics, and communicate using neural signals. Neurotech is also playing a crucial role in mental health treatment, with transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS) emerging as effective therapies for treatment-resistant depression and anxiety disorders. The growing adoption of neurofeedback devices for cognitive training, focus improvement, and stress management is further expanding the neurotech landscape. Advances in artificial intelligence (AI) and machine learning are enabling real-time neural data analysis, paving the way for precision neurotherapies. As the global population ages and neurodegenerative disorders become more prevalent, neurotech devices are increasingly being integrated into mainstream healthcare, enhancing neurological rehabilitation and expanding human potential through direct brain-machine interaction.

What Challenges Are Slowing the Adoption of Neurotech Devices?

Despite rapid advancements, neurotech devices face several challenges that hinder widespread adoption. One of the key obstacles is the high cost of development and implementation, particularly for implantable BCIs and advanced neuromodulation therapies. Ethical and regulatory concerns surrounding brain-computer interfaces and neurostimulation technologies pose additional hurdles, as long-term safety, privacy, and potential misuse of neurodata remain pressing concerns. The complexity of brain signal interpretation and variability in patient responses also challenge the reliability and effectiveness of neurotech applications. Many neurotech devices require significant computational power and real-time processing capabilities, leading to concerns about energy consumption and device miniaturization. Additionally, public skepticism regarding invasive brain implants and concerns over data security in connected neurotech solutions slow adoption rates. Standardization across different neurotech platforms and interoperability with existing healthcare systems remain unresolved issues, making integration into clinical workflows more difficult. Addressing these challenges requires increased investment in neuroethics, cross-disciplinary collaboration between neuroscientists and engineers, and advancements in low-power, wireless neurotech solutions that improve user accessibility and safety.

How Are Innovations Pushing the Boundaries of Neurotech?

The neurotech market is undergoing rapid innovation, with new technologies enhancing the functionality, accuracy, and accessibility of brain-machine interfaces and neuromodulation devices. The development of high-density, flexible neural implants is allowing for improved brain signal acquisition and longer-lasting device performance. AI-powered BCIs are enabling faster and more accurate decoding of neural activity, opening doors for direct thought-controlled devices. The rise of non-invasive neurotech solutions, such as functional near-infrared spectroscopy (fNIRS) and dry-electrode EEG headsets, is making neurotechnology more accessible for consumer applications, including gaming, productivity enhancement, and meditation. Neurostimulation is also evolving, with closed-loop feedback systems that automatically adjust stimulation parameters based on real-time brain activity, improving efficacy for conditions such as epilepsy and chronic pain. Advances in wireless neurotech are enabling seamless connectivity between brain sensors and external devices, reducing the need for invasive procedures. Additionally, the convergence of neurotech with augmented reality (AR) and virtual reality (VR) is opening new possibilities in cognitive therapy, pain management, and neurorehabilitation. As innovation accelerates, neurotech is becoming more sophisticated, personalized, and integrated into everyday life, transforming the future of human-computer interaction.

What Is Driving the Growth of the Neurotech Devices Market?

The growth in the neurotech devices market is driven by several factors, including the increasing prevalence of neurological disorders, rising investments in brain-machine interface research, and growing consumer interest in cognitive enhancement technologies. The demand for neurostimulation therapies is surging as non-invasive and implantable devices gain FDA approvals for conditions such as epilepsy, depression, and Parkinson’s disease. The expansion of AI-driven brain-computer interfaces is further fueling market growth, with companies developing mind-controlled prosthetics, assistive communication tools, and hands-free computing solutions. The growing adoption of wearable neurotech in wellness and mental health, including neurofeedback devices for sleep improvement and stress reduction, is expanding the market beyond clinical applications. The push for personalized medicine and real-time brain monitoring is driving investment in next-generation EEG and neuroimaging technologies, enhancing the precision of neurological diagnostics. Additionally, government initiatives supporting neurotechnology research, such as the U.S. BRAIN Initiative and the European Human Brain Project, are fostering innovation and commercialization. As neurotech devices continue to evolve, their applications are expanding across healthcare, consumer technology, defense, and human augmentation, positioning the market for rapid growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Neurotech Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation); Condition Type (Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy, Urinary & Fecal Incontinence, Hearing Conditions, Depression, Sleep Disorders)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurotech Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Neurological Disorders Spurs Demand for Advanced Neurotech Solutions
    • Rising Investment in Brain-Computer Interface (BCI) Research Expands Addressable Market Opportunity
    • Increasing Integration of AI and Machine Learning in Neurotech Devices Strengthens Business Case for Adoption
    • Heightened Consumer Interest in Cognitive Enhancement Technologies Drives Demand for Wearable Neurotech
    • Surge in Mental Health Awareness Throws the Spotlight on Non-Invasive Neuromodulation Therapies
    • Rapid Advancements in Miniaturization and Implantable Device Technology Propel Growth in Medical Neurodevices
    • Adoption of Personalized Neurological Therapies Accelerates Demand for Patient-Centric Neurotech Solutions
    • Favorable Regulatory Approvals for Novel Neurostimulation Devices Sustain Growth Momentum
    • Rise in Telehealth and Remote Monitoring Trends Drives Adoption of Connected Neurotech Platforms
    • Growing Use of Neurotech Devices in Rehabilitation and Stroke Recovery Expands Clinical Application Scope
    • Increasing Demand for Non-Pharmacological Treatment Alternatives Generates Opportunity for Neurotherapy Devices
    • Military and Defense Interest in Cognitive Augmentation Technologies Opens Up New Strategic Market Frontiers
    • Aging Global Population and Increasing Incidence of Neurodegenerative Diseases Drive Device Penetration
    • Integration of Cloud and Big Data Analytics in Neurological Monitoring Enhances Market Attractiveness
    • Venture Capital and Strategic Partnerships in Neurotech Innovation Accelerate Market Commercialization
    • Emergence of Consumer Neurotech in Wellness and Gaming Sectors Drives Market Diversification
    • High Cost of R&D and Commercialization Challenges Present Barriers to Entry for Emerging Players
    • Growing Use of EEG and Neuroimaging in Brain Research Spurs Demand for Advanced Diagnostic Tools
    • Evolving Regulatory Landscape and Reimbursement Policies Shape Market Dynamics and Access
    • Increasing Cross-Disciplinary Collaboration in Neuroscience, Engineering, and Data Science Fuels Innovation Pipeline
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurotech Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neuroprostheses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Neurosensing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Neurorehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hearing Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Sleep Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CHINA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • INDIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제